Prof. Dr. Ikuro Suzuki – Pharmacology – Best Researcher Award

Posted on by Innovator Awards

Prof. Dr. Ikuro Suzuki - Pharmacology - Best Researcher Award

Tohoku Institute of Technology - Japan

Author Profile 

ORCID 

🎓 Early academic pursuits

Ikuro Suzuki began his scholarly journey at the prestigious university of tokyo, where he earned his ph.d. in march 2008 from the department of advanced interdisciplinary studies, graduate school of arts and sciences. during his doctoral research, he was awarded the esteemed dc1 research fellowship by the japan society for the promotion of science, reflecting his strong potential in advanced scientific exploration. this early phase of his academic development laid a solid foundation in cutting-edge technologies, including power electronics, biomedical engineering, and interdisciplinary innovation.

💼 Professional endeavors

After completing his doctoral studies, suzuki embarked on a dynamic academic career across several renowned institutions. he began as an assistant professor at the institute of biomaterials and bioengineering, tokyo medical and dental university (2008–2010), followed by another assistant professorship at the faculty of applied biological sciences, tokyo university of technology Pharmacology (2010–2014). in 2014, he joined the tohoku institute of technology, where he steadily rose through the ranks—first as a lecturer, then as an associate professor, and now as a full professor in the department of electrical and electronic engineering. concurrently, he has held influential roles including visiting researcher at riken and director of the air research institute.

🔬 Contributions and research focus

Professor suzuki's research integrates the fields of electrical engineering, biomedical systems, and intelligent electronics, with a strong focus on power electronics. his work bridges theory and practical innovation in electronic circuit design, control systems, and biomedical instrumentation. his multidisciplinary approach enables advancements in devices and technologies that Pharmacology support healthcare and automation. more recently, his research has included applications of power electronics in drug discovery systems and smart diagnostics, reflecting a seamless fusion of engineering and life sciences.

🌏 Impact and influence

Suzuki's influence extends beyond academic instruction into national and international research collaborations. his role as director of the air research institute has driven innovation in artificial intelligence and robotics, while his visiting researcher position at riken places him at the forefront of regenerative medicine and drug development technologies. by founding vitrovo inc. in Pharmacology 2023, he further demonstrated his commitment to translating academic innovation into commercial solutions, particularly in the context of advanced electronics and biotechnology. his work continues to contribute to advancements in power electronics and its applications in health tech.

📚 Academic cites

As an academic, suzuki has published numerous peer-reviewed papers in respected journals spanning electronic systems, biomedical engineering, and interdisciplinary science. his citations reflect a growing recognition of his work across fields, particularly in the application of intelligent control systems and power electronics to biomedical applications. his scholarly output is often referenced by peers working on next-generation devices and adaptive systems.

🧭 Legacy and future contributions

With a career that bridges academia, industry, and interdisciplinary innovation, professor ikuro suzuki's legacy lies in his integrative vision of engineering. as he continues to lead in education, research, and entrepreneurship, his future contributions are expected to focus on enhancing the functionality and intelligence of biomedical devices through power electronics, artificial intelligence, and compact embedded systems. he aims to mentor a new generation of engineers capable of navigating the convergence of electronics and life sciences.

Notable Publications 

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Biosensors and Bioelectronics (2025-11)

  • Title: Advanced Neural Activity Mapping in Brain Organoids via Field Potential Imaging with Ultra-High-Density CMOS Microelectrodes
    Author(s): Remi Yokoi, Naoki Matsuda, Yuto Ishibashi, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-05-25

  • Title: Analysis of β Rhythm Induction in Acute Brain Slices Using Field Potential Imaging with Ultra-High-Density CMOS-Based Microelectrode Array
    Author(s): Hiroto Takahashi, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Development of a Microelectrode Array System for Simultaneous Measurement of Field Potential and Glutamate Release in Brain Slices
    Author(s): Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

  • Title: Field Potential Imaging in Human iPSC-Derived Cardiomyocytes Using UHD-CMOS-MEA
    Author(s): Naoki Matsuda, Nami Nagafuku, Kazuki Matsuda, Yuto Ishibashi, Tomohiko Taniguchi, Yusaku Matsushita, Norimasa Miyamoto, Takashi Yoshinaga, Ikuro Suzuki
    Journal: Preprint (bioRxiv), 2025-04-04

Mr. Kyle Frey – Pharmaceutical Manufacturing – Best Researcher Award 

Posted on by Innovator Awards

Mr. Kyle Frey - Pharmaceutical Manufacturing - Best Researcher Award 

Quotient Sciences - United States

Author Profile 

ORCID 

🎓 Early academic pursuits

Kyle Frey graduated summa cum laude from the university of delaware, where his academic brilliance earned him early acceptance into thomas jefferson medical university. this strong foundation in pharmaceutical sciences laid the groundwork for a career defined by precision, innovation, and scientific curiosity. his early academic journey was marked by deep analytical thinking and a desire to explore cross-disciplinary fields such as acoustical engineering, materials science, and even power electronics in drug formulation.

💼 Professional endeavors

Kyle’s professional journey began with a pivotal role at dupont, where he was instrumental in creating the first knowledge database for thin film development in oral drug delivery systems. at quotient sciences, he introduced advanced predictive stability testing models and transformed the organization’s formulation capabilities. kyle spent over five years independently exploring resonant acoustic mixing technology, ultimately becoming one of the leading figures in this niche field. his expertise in power electronics helped bridge concepts between acoustic forces and pharmaceutical behavior, guiding groundbreaking discoveries in mixing efficiency and dosage homogeneity.

🔬 Contributions and research focus

Kyle Frey’s research revolves around resonant acoustic mixing (ram) technologies, a field that combines theoretical acoustics, engineering, and pharmaceutical science. after three months of rigorous experimentation and more than 20 months of conceptual development, he unveiled the first substantial body of work on the subject at aaps pharmsci 360 in 2023. his first two research papers—published in pharmaceutical research (nov. 2023) and the international journal of pharmaceutics (apr. 2025)—laid the conceptual groundwork for his current primary Pharmaceutical Manufacturing manuscript. his studies challenge conventional mixing paradigms and incorporate principles from power electronics to redefine how acoustic energy interacts with pharmaceutical particles.

🌟 Impact and influence

Kyle’s work has not only pushed the envelope in pharmaceutical mixing technologies but has also opened up a multidisciplinary approach to formulation science. his blend of curiosity, perseverance, and innovation has led to widespread recognition within the pharmaceutical community. his pioneering use of acoustics, informed by principles in power electronics, has Pharmaceutical Manufacturing inspired many professionals to reconsider how energy input and material properties can be harmonized for novel drug delivery systems. by developing a comprehensive framework for understanding ram, he has created a new pathway for scientists worldwide to follow.

📚 Academic cites

To date, kyle frey has three highly cited original publications: two in prestigious peer-reviewed journals (nov. 2023 and apr. 2025) and one presented at aaps pharmsci 360 in 2023. his publications have gained attention for their originality and depth, reflecting the five years of independent work he dedicated to the field. several other manuscripts—one completed and Pharmaceutical Manufacturing another in progress—promise to further expand the academic community’s understanding of resonant acoustic phenomena. his upcoming third manuscript is anticipated to synthesize all prior work and become a definitive resource in the domain.

🔭 Legacy and future contributions

Kyle's journey began with a simple thought—"i wonder if sound can be used to monitor crystallization processes"—and evolved into a life-long mission. his passion for this subject has shaped his identity as a scientist and continues to guide his work. with five total manuscripts (including two pending review articles), kyle aims to leave a lasting legacy in pharmaceutical acoustics and formulation science. his commitment to integrating advanced scientific theories, including power electronics, into real-world applications ensures that his contributions will influence future generations of researchers.

Notable Publications 

  • Title: Sample preparation techniques to enhance uniformity of Low-Dose blends mixed by resonant acoustic mixing technology
    Author: Kyle Frey
    Journal: International Journal of Pharmaceutics

  • Title: Use of Resonant Acoustic Mixing Technology for Ultra-Low-Dose Blending in a Single-Step Mixing Process
    Authors: Kyle Frey, Helen Baker, Dale K. Purcell, Andrew L. Lewis, David A. Engers
    Journal: Pharmaceutical Research

  • Title: Use of Resonant Acoustic Technology for Ultra-Low Dose Blending in a Single-Step Mixing Process
    Author: Kyle Frey
    Journal: AAPS PharmSci 360 (Conference Poster)

Assoc. Prof. Dr Meenakshi Dhanawat – Pharmacy – Best Researcher Award

Posted on by Innovator Awards

Assoc. Prof. Dr Meenakshi Dhanawat - Pharmacy - Best Researcher Award

Amity Institute of Pharmacy, Amity University Haryana - India 

AUTHOR PROFILE 

SCOPUS 

ORCID 

EARLY ACADEMIC PURSUITS 🎓

Meenakshi Dhanawat's academic journey began with a solid foundation in Pharmaceutical Sciences, completing her B. Pharm at Lachoo Memorial College of Science & Technology, Jodhpur, Rajasthan in 2005. She further honed her expertise by pursuing a Master's in Medicinal Chemistry at the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, where she developed a deep interest in synthetic chemistry, drug delivery systems, and nanotechnology. Her passion for advancing pharmaceutical science led her to complete a Ph.D. in Pharmaceutical Chemistry from the Department of Pharmaceutics at IIT-BHU, Varanasi, in 2012. During her doctoral studies, she focused on the development of innovative drug delivery systems and therapeutic strategies to enhance drug bioavailability.

PROFESSIONAL ENDEAVORS 💼

Dr. Dhanawat has had a dynamic professional career spanning over 17 years in teaching and research. She began her career as a Quality Manager at Nector Life Science Ltd., where she contributed to ensuring the quality and efficacy of pharmaceutical products. She then served as an Assistant Professor and Head of the Department at Mewar University, Chittorgarh, Rajasthan, from 2013 to 2016. Dr. Dhanawat continued her academic journey at Maharishi Markandeshwar (Deemed to be University) in Mullana, Ambala, where she held the position of Assistant Professor and later Associate Professor. Her contributions to academia expanded as she joined Amity University in Gurugram as an Associate Professor in December 2022, where she continues to shape the future of pharmacy education.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Dr. Dhanawat's research expertise lies in synthetic chemistry, heterocyclic chemistry, nanotechnology, and drug delivery systems. She has worked extensively on designing prodrugs and co-drug drug delivery systems to improve therapeutic efficacy. Her research also focuses on the complexation of polymers in drug delivery systems, aiming to enhance the controlled release of Pharmacy active pharmaceutical ingredients. Over the years, she has contributed significantly to the field through numerous publications and innovative research work in pharmaceutical sciences. She has authored 71 research/review articles, contributed to six books, and edited one book. Her work on drug design and delivery has further extended to patented innovations aimed at advancing pharmaceutical technology.

ACCELERATING IMPACT THROUGH PATENTS AND INNOVATIONS 📑

Dr. Dhanawat's innovative spirit is exemplified by her contribution to pharmaceutical technology through five granted patents. These patents include designs for cutting-edge pharmaceutical Pharmacy devices, such as an inclined paw grip and climbing apparatus for rodents, a handheld nanoparticle size analyzer, and intelligent dosing control systems for pharmaceuticals. Additionally, she has pioneered innovations in pharmaceutical waste disposal units and UV chambers for pharmaceutical processes. These patents not only underscore her technical expertise but also contribute significantly to the advancement of the pharmaceutical and healthcare industries.

ACCOLADES AND RECOGNITION 🏆

Dr. Dhanawat’s outstanding contributions to the field of pharmaceutical sciences have earned her numerous accolades and recognition within academic and professional circles. She is a Pharmacy sought-after reviewer for scientific journals and has contributed to several thematic issues in the field. Her extensive research, innovative patents, and contributions to academia have made her a recognized leader in pharmaceutical sciences. Her achievements in drug design, nanotechnology, and polymer chemistry continue to inspire the next generation of researchers and practitioners in the field.

LEGACY AND INFLUENCE ON FUTURE RESEARCH 🌍

Dr. Dhanawat's legacy is marked by her impact on the development of novel drug delivery systems, which have improved the efficacy of pharmaceuticals and enhanced patient outcomes. Through her research, she has inspired many students and professionals to explore the intersection of synthetic chemistry, nanotechnology, and drug delivery. As a mentor and educator, she continues to guide the future of pharmaceutical sciences, fostering innovation in drug design and therapeutic systems. Her forward-thinking research, combined with her extensive academic experience, ensures that she remains a key influencer in shaping future pharmaceutical technologies.

NOTABLE PUBLICATIONS 

  1. Title: Auvelity: A New Era in Medicine - Unraveling the Multifaceted Benefits of Dextromethorphan/Bupropion Combination
    Authors: Anchal Dhawan, Sunayna Choudhary, Sumeet Gupta, Abhishek Chander, Meenakshi Dhanawat
    Journal: Current Drug Therapy, 2024-09
    DOI: 10.2174/1574885519666230913105725
  2. Title: Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals
    Authors: Dakshita Hardatt, Manju Devi, Sonal Vyas, Gurvinder Singh, Jyoti Jain, Sumeet Gupta, Meenakshi Dhanawat
    Journal: Current Diabetes Reviews, 2024-01
    DOI: 10.2174/1573399819666230331083715
  3. Title: Quinazolinone: Pharmacophore with Endless Pharmacological Actions
    Authors: Meenakshi Dhanawat, Sumeet Gupta, Somdutt Mujwar
    Journal: Current Indian Science, 2023
    DOI: 10.2174/2210299X02666221125101550
  4. Title: Synthesis, Biological Evaluation and in Silico Studies of Some New Analogues of 3,5-Disubstituted Thiazolidin-2,4-Dione
    Authors: Harsh Kumar, Aastha Sharma, Davinder Kumar, Minakshi Gupta Marwaha, Meenakshi Dhanawat, Navidha Aggarwal, Rakesh Kumar Marwaha
    Journal: Future Medicinal Chemistry, 2023-12
    DOI: 10.4155/fmc-2023-0237
  5. Title: Assessment of Peripheral Neuropathy Pain by Biothesiometer in Diabetes Mellitus Patients
    Authors: Manju Devi, Sukhdeep Singh, Meenakshi Dhanawat, Kirti Gupta, Sumeet Gupta, B K Agarwal, Inderjeet Verma, Parminder Nain
    Journal: Journal of Young Pharmacists, 2023-01-01
    DOI: 10.5530/097515050431